AMR in the Light of COVID-19 - A Webinar Series Each of us is now living in a world with a nearly untreatable virus - but COVID-19 is not the only threat that we are facing. Many bacterial and fungal infections that were previously considered treatable are no longer responding to the drugs designed to […]

CARB-X speakers include Nadia Cohen, Alliance Manager. The World Vaccine Congress is an award-winning series of conferences and an exhibition that has grown to become the largest and most established vaccine meeting of its kind across the globe. Due to the global pandemic, we have made a decision to run the 2020 congress VIRTUALLY. To […]

Speakers: Value of a pre-IND interaction with the US FDA during late lead optimization: Bugworks experience - Bala Subramanian, Bugworks Research Inc. Amicidins: Building clinical and regulatory strategies for non-traditional products to prevent and treat life-threatening infections - Michael P. Bevilacqua, Amicrobe, Inc. Discovery and development of microbiome therapeutics using reverse translation - Matthew Henn […]

AMR in the Light of COVID-19 - A Webinar Series Each of us is now living in a world with a nearly untreatable virus - but COVID-19 is not the only threat that we are facing. Many bacterial and fungal infections that were previously considered treatable are no longer responding to the drugs designed to […]

Speakers include Kevin Outterson, Executive Director of CARB-X. The ESCMID Conference on Coronavirus Disease (ECCVID) will take place online from Wednesday 23rd to Friday 25th September 2020 and will cover all aspects of COVID-19. ECCVID will feature a comprehensive scientific programme that will span a wide range of topics surrounding this emerging threat.  COVID-19 is a major […]

Participants include Kevin Outterson, Executive Director of CARB-X. The world needs a new generation of antibiotics to address the rapid growth in antibiotic-resistant bacteria. The UK government’s 2014 Review on Antimicrobial Resistance estimated that such bacteria could result in the deaths of 10 million people a year by 2050 and an accumulated cost of up […]

AMR in the Light of COVID-19 - A Webinar Series Each of us is now living in a world with a nearly untreatable virus - but COVID-19 is not the only threat that we are facing. Many bacterial and fungal infections that were previously considered treatable are no longer responding to the drugs designed to […]

The September PACCARB meeting, held virtually, will focus on welcoming eight new liaison members and on the impact of COVID-19 and its affect on antimicrobial resistance (AMR). Topics will include presentations on the COVID-19 mortality rate due to secondary acquired infections, antibiotic stewardship practices during a pandemic, disruptions in the agricultural industry due to COVID-19 […]

Moderator: Betsy Wonderly Trainor, Alliance Director, CARB-X Speakers: Peter Haug – CFO & Co-Founder, Head of Business Development & Licensing, Noscendo GmbH Piotr Gastrecki – CTO, ScopeFluidics Rosemarie Preyer – GenID GmbH

As the scientific community search for alternatives to broad spectrum antibiotics, phage therapy has re-emerged as a viable solution to tackle the global health challenge of anti-microbial resistance. As such, the 2nd Bacteriophage Therapy Summit returns digitally as a dedicated platform for leaders in industry and academia to accelerate the discovery and translation of bacteriophage research into targeted […]